论文部分内容阅读
目的观察奥拉西坦联合尼莫地平治疗高血压脑出血的临床疗效。方法 50例高血压脑出血患者,随机分成治疗组(26例)和对照组(24例)。对照组给予脑出血常规治疗,治疗组在对照组基础上给予奥拉西坦联合尼莫地平治疗。21 d后比较治疗效果及治疗前后神经功能缺损评分(NIHSS)、简易精神状态量表评分(MMSE)及生活质量评分(Barthel)。结果治疗组总有效率为88.5%,对照组总有效率为62.5%。两组总有效率比较,治疗组优于对照组,差异有统计学意义(P<0.05)。治疗21 d后,治疗组NIHSS评分较治疗前及对照组治疗后下降(P<0.05),而MMSE、Barthel评分明显高于治疗前及对照组治疗后(P<0.05)。结论奥拉西坦联合尼莫地平能能明显改善高血压脑出血患者神经功能缺损程度及认知功能,提高生活质量及预后效果。
Objective To observe the clinical efficacy of oxiracetam combined with nimodipine in the treatment of hypertensive intracerebral hemorrhage. Methods Fifty patients with hypertensive intracerebral hemorrhage were randomly divided into treatment group (26 cases) and control group (24 cases). The control group was given routine treatment of cerebral hemorrhage. The treatment group was given oxiracetam combined with nimodipine on the basis of the control group. After 21 days, the therapeutic effect, NIHSS score, MMSE and Barthel score were compared before and after treatment. Results The total effective rate was 88.5% in the treatment group and 62.5% in the control group. The total effective rate of two groups, the treatment group was better than the control group, the difference was statistically significant (P <0.05). After 21 days of treatment, the NIHSS scores of the treatment group decreased significantly (P <0.05), but the scores of MMSE and Barthel were significantly higher than those before treatment and control group (P <0.05). Conclusion Oxiracetam combined with nimodipine can significantly improve the degree of neurological deficit and cognitive function in patients with hypertensive intracerebral hemorrhage and improve quality of life and prognosis.